Steven J. Goldstein and Karlyn A. Schnapp provided numerous patent freedom-to-practice and invalidity opinions to support ANDA filings of a major generic pharmaceutical company, including a first to file ANDA filing for an oncology drug.
-
Freedom-to-Practice: Oncology Drug
Stay ahead of the law.
Subscribe to receive email updates and choose your topics.